Synthesis, docking and acetylcholinesterase inhibitory evaluation of (E)-3-(4-(diethylamino) phenyl)-1-phenylprop- 2-en-1-one derivatives with probable anti-Alzheimer effects

Alireza Aliabadi; Ahmad Mohammadi-Farani; Mohammad Javad Ahmadvand; marzieh Rahmani Khajouei

Outlines

Abstract
Copyright

Synthesis, docking and acetylcholinesterase inhibitory evaluation of (E)-3-(4-(diethylamino) phenyl)-1-phenylprop- 2-en-1-one derivatives with probable anti-Alzheimer effects

Author(s):

Alireza Aliabadi^{1, 2,*},

Ahmad Mohammadi-Farani^{1, 3},

Mohammad Javad Ahmadvand^{2, 4},

marzieh Rahmani Khajouei⁵

1Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

3Department of Pharmacology, Toxicology and Medical Services, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

4Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

5Isfahan Pharmaceutical Sciences Research Center, Isfahan, Iran

Journal of Reports in Pharmaceutical Sciences:Vol. 6, issue 2; 134-141

Published online:Jul 16, 2017

Article type:Research Article

Received:May 02, 2017

Accepted:Jul 10, 2017

How to Cite:Alireza AliabadiAhmad Mohammadi-FaraniMohammad Javad Ahmadvandmarzieh Rahmani KhajoueiSynthesis, docking and acetylcholinesterase inhibitory evaluation of (E)-3-(4-(diethylamino) phenyl)-1-phenylprop- 2-en-1-one derivatives with probable anti-Alzheimer effects.J Rep Pharm Sci.6(2):e147611.

Abstract

Alzheimer's disease (AD) as form of senile dementia is a cognitive and neurodegenerative disorder as well as behavioral and psychological problems in the geriatric people. The disease is characterized by memory deficit as well as decline in daily activities. The deficiency of the cholinergic system is one the main causes of the disease. Some medications such as donepezil are capable of enhancement of the acetylcholine neurotransmitter via the inhibition of the acetylcholinesterase (AChE) enzyme. According to the positive background of the chalcone derivatives in inhibition of AChE, a new series of chalcone derivatives were synthesized using aldol condensation procedure and their enzyme inhibitory potency were assessed by Ellman’s test. Some of the tested derivatives demonstrated superior activity than donepezil (IC50 = 0.41 ± 0.09 μM) especially methoxylated compounds 3h (2-OCH3, IC50 = 0.1 ± 0.02 μM), 3i (3-OCH3, IC50 = 0.12 ± 0.03 μM) and 3j (4-OCH3, IC50 = 0.39 ± 0.04 μM). Compound 3b (3-Cl, IC50 = 0.13 ± 0.03 μM) also possessed higher activity than donepezil. Molecular docking investigation also confirmed an effective hydrogen bonding interaction of 3h with AChE. In conclusion, the synthesized compounds could be suggested as new anti-acetylcholinesterase lead compounds.

Keywords

comments